Stock Expert AI

RXL ETF — Holdings & Analysis

The ProShares Ultra Health Care ETF (RXL) is designed for investors seeking amplified daily exposure to the health care sector. With approximately $0.08 billion in assets under management, RXL aims to deliver twice the daily performance of the S&P Health Care Select Sector Index. However, this leveraged approach comes with a higher expense ratio of 1.07%, significantly above the category average. The fund's top holdings include ProShares GENIUS Money Market ETF (IQMM), Eli Lilly and Co (LLY), and Johnson & Johnson (JNJ), reflecting a concentrated bet on leading healthcare companies.

ProShares - Ultra Health Care (RXL) ETF — Price, Holdings & Analysis

The ProShares Ultra Health Care ETF (RXL) is designed for investors seeking amplified daily exposure to the health care sector. With approximately $0.08 billion in assets under management, RXL aims to deliver twice the daily performance of the S&P Health Care Select Sector Index. However, this leveraged approach comes with a higher expense ratio of 1.07%, significantly above the category average. The fund's top holdings include ProShares GENIUS Money Market ETF (IQMM), Eli Lilly and Co (LLY), and Johnson & Johnson (JNJ), reflecting a concentrated bet on leading healthcare companies.

ETF Genel Bakış

ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select SectorSM Index.
ProShares Ultra Health Care (RXL) employs a leveraged strategy, seeking to provide two times the daily performance of the S&P Health Care Select Sector Index. This approach is designed for sophisticated investors with a short-term horizon who are looking to capitalize on anticipated daily movements in the health care sector. The fund achieves this through a combination of equity holdings and derivatives. RXL's portfolio is concentrated, with its top holdings including ProShares GENIUS Money Market ETF (IQMM) at 10.73%, Eli Lilly and Co (LLY) at 10.22%, and Johnson & Johnson (JNJ) at 7.33%. Sector allocation is heavily weighted towards Healthcare at 74.1%, followed by Cash & Others at 14.1% and Financial Services at 11.8%. RXL's leveraged nature differentiates it from traditional healthcare ETFs, which typically offer unleveraged exposure to the sector. Investors should understand that leveraged ETFs are not designed for long-term holding and can experience significant volatility.

Risk Metrikleri

Investing in RXL involves several risks that investors should carefully consider. As a leveraged ETF, RXL is subject to amplified volatility, meaning that both gains and losses can be magnified. The fund's 3-year beta of 1.06 indicates that it is slightly more volatile than the market. The high expense ratio of 1.07% can create a significant drag on performance over time, especially when compounded by the effects of leverage. RXL's concentration in the health care sector (74.1%) exposes it to sector-specific risks, such as regulatory changes, patent expirations, and shifts in healthcare policy. Furthermore, the fund's top holdings, including Eli Lilly and Johnson & Johnson, represent a significant portion of the portfolio, increasing concentration risk. Due to the fund's leveraged nature, past performance does not guarantee future results.

Gider Oranı

1.07%

En İyi Varlıklar

Sektör Dağılımı

  • Healthcare: 74.1%
  • Cash & Others: 14.1%
  • Financial Services: 11.8%
  • United States: 83.3%
  • Other: 14.8%
  • Ireland: 1.8%

Temettü Verimi

0.00%
  • <a href="/etf/xlf">State Street Financial Select Sector SPDR ETF (XLF)</a> — 0.08% expense ratio
  • <a href="/etf/xlk">State Street Technology Select Sector SPDR ETF (XLK)</a> — 0.08% expense ratio
  • <a href="/etf/eem">iShares MSCI Emerging Markets ETF (EEM)</a> — 0.72% expense ratio
  • <a href="/etf/spy">State Street SPDR S&P 500 ETF Trust (SPY)</a> — 0.09% expense ratio
  • <a href="/etf/rwde">Direxion MSCI Developed Over Emerging Markets ETF (RWDE)</a> — 0.53% expense ratio
  • <a href="/etf/fine">Themes European Luxury ETF (FINE)</a> — 0.35% expense ratio
  • <a href="/etf/mj">Amplify Alternative Harvest ETF (MJ)</a> — 0.75% expense ratio
  • <a href="/etf/defa">iShares Adaptive Currency Hedged MSCI EAFE ETF (DEFA)</a> — 0.35% expense ratio
  • <a href="/etf/onln">ProShares - Online Retail ETF (ONLN)</a> (Equity) — 0.58% ER
  • <a href="/etf/nobl">ProShares - S&P 500 Dividend Aristocrats ETF (NOBL)</a> (Equity) — 0.35% ER
  • <a href="/etf/ycs">ProShares - UltraShort Yen (YCS)</a> (Alternatives) — 0.95% ER
  • <a href="/etf/skyu">ProShares - Ultra Nasdaq Cloud Computing (SKYU)</a> (Equity) — 5.04% ER
  • <a href="/etf/tolz">ProShares - DJ Brookfield Global Infrastructure ETF (TOLZ)</a> (Equity) — 0.46% ER
  • <a href="/etf/tmdv">ProShares - Russell U.S. Dividend Growers ETF (TMDV)</a> (Equity) — 0.35% ER

Risk Metrikleri

  • Beta: 1.06

Sorular & Cevaplar

What is RXL and what does it track?

ProShares Ultra Health Care (RXL) is an exchange-traded fund (ETF) that seeks to provide daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of the S&P Health Care Select Sector Index. This means RXL aims to double the daily gains or losses of the index, which tracks a broad range of companies in the health care sector. The fund's objective makes it suitable for investors with a short-term investment horizon who are looking to make tactical bets on the health care industry. However, due to the effects of compounding, RXL is not designed for long-term holding.

What is the expense ratio for RXL?

The expense ratio for ProShares Ultra Health Care (RXL) is 1.07%. This means that for every $10,000 invested in the fund, $107 is deducted annually to cover operating expenses. This expense ratio is significantly higher than the average expense ratio for equity ETFs, which is around 0.44%. the may be worth researching impact of this higher expense ratio on their overall returns, especially over longer investment periods. The higher expense ratio reflects the cost of managing a leveraged ETF.

What are the top holdings in RXL?

As of 2026-03-15, the top holdings in ProShares Ultra Health Care (RXL) are: 1) ProShares GENIUS Money Market ETF (IQMM) at 10.73%, which is used for cash management; 2) Eli Lilly and Co (LLY) at 10.22%, a major pharmaceutical company; 3) Johnson & Johnson (JNJ) at 7.33%, a diversified healthcare company; 4) AbbVie Inc (ABBV) at 5.02%, another leading pharmaceutical company; and 5) Merck & Co Inc (MRK) at 3.76%. These holdings represent a significant portion of the fund's assets, indicating a concentrated portfolio focused on large-cap healthcare companies.

Is RXL a good long-term investment?

ProShares Ultra Health Care (RXL) is generally not considered a suitable long-term investment due to its leveraged nature. The fund aims to deliver twice the daily performance of the S&P Health Care Select Sector Index, which can lead to amplified gains in the short term. However, the effects of compounding and volatility can significantly erode returns over longer periods. The fund's high expense ratio of 1.07% also contributes to potential long-term underperformance. Investors seeking long-term exposure to the health care sector may want to consider traditional, unleveraged ETFs with lower expense ratios. Past performance does not guarantee future results.

How does RXL compare to similar ETFs?

RXL differentiates itself from other healthcare ETFs through its leveraged strategy, aiming for twice the daily performance of its benchmark. Most healthcare ETFs offer unleveraged exposure. RXL's expense ratio of 1.07% is considerably higher than many traditional healthcare ETFs, which typically have expense ratios below 0.50%. RXL's AUM of $0.08 billion is also relatively small compared to larger, more established healthcare ETFs. Investors should weigh the potential for amplified gains against the higher costs and increased volatility associated with RXL's leveraged approach when comparing it to similar ETFs.

Does RXL pay dividends?

As of 2026-03-15, ProShares Ultra Health Care (RXL) has a dividend yield of 0.00%. This indicates that the fund does not currently distribute any dividends to its shareholders. Investors seeking income from their investments may want to consider other healthcare ETFs that offer dividend payouts. The fund's focus is primarily on capital appreciation through leveraged exposure to the health care sector, rather than generating income through dividends.